Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethality
Michail Shipitsin(C4 Therapeutics (United States)), Peter Blume‐Jensen(C4 Therapeutics (United States))
Cited by 61
Related Papers
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
|Journal of Clinical Investigation|2011|928
Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
|Clinical Cancer Research|2010|397